Former bedside RN turned oncologic mutations nerd | reformed narrative artist |
Joined April 2020
- Tweets 1,061
- Following 148
- Followers 95
- Likes 1,889
38 Photos and videos
Tell me, @ColumbusPolice what part of this is protect or serve? We were treating people in an alley and you gleefully chased us and sprayed another medic from a distance of inches and LAUGHED about it. #columbusprotest #ColumbusOhio
71
1,501
2,745
Kate retweeted
22 Dec 2023
#PaperoftheDay: "Impact of MET targeting on tumor-associated angiogenesis and growth of MET mutations-driven models of liver cancer"
DOI: doi.org/10.18632/genesandcan… #genes #oncology #OA
2
32
Kate retweeted
New method from the Yale School of Public Health analyzes how mutations interact to alter tumor development. The innovation should make it easier to develop targeted therapies that anticipate the evolutionary path of a cancer, then corner and eradicate it. buff.ly/48DQlpy
1
1
37
Kate retweeted
1 Nov 2023
🧬 Exploring the endless potential of #Bioinformatics in #Oncology! From deciphering genetic mutations to personalized treatment plans, this field is revolutionizing cancer research and patient care. 🌟 #CancerResearch #PrecisionMedicine #DataScience
2
253
Kate retweeted
5 Nov 2023
Ibrutinib bortezomib elicited durable responses in patients w/ R/R MCL and high-risk features such as a Ki-67 over 30%, blastoid or pleomorphic variant, p53 overexpression, & TP53 mutations/deletions. #lymsm #oncology onclive.com/view/ibrutinib-b…
2
2
1,100
I wish more NGS testing companies had reports as easily readable as F1s 🥰 looking at you, @carisls
13 Oct 2023
The #FDA approved FoundationOne® CDx & FoundationOne Liquid CDx as companion diagnostics for the identification of patients with metastatic #NSCLC with BRAF V600E mutations, & who may benefit from treatment with encorafenib binimetinib.
targetedonc.com/view/fda-oka…
38
Kate retweeted
14 Oct 2023
Chemo Vs 🎯 mutation. Why it’s important to look out for actionable mutations/NGS.
#lcsm #gism @VivekSubbiah @esinghimd @marklewismd @DrYukselUrun #egfr #brca #braf #ntrk #ret #ros #her2 @BijoyTelivala @EGFRResisters @KRASKickers @pashtoonkasi #OncTwitter #MedTwitter #OncEd
1
12
67
18,561
Kate retweeted
21 Sep 2023
Zero drag queens have been arrested in Tennessee this year for raping or sexually abusing children.
Over 30 faith leaders have. wsmv.com/2023/09/20/evangeli…
412
8,405
25,587
1,200,324
Kate retweeted
31 Aug 2023
medicaltrend.org/2023/08/31/…
12 ALK Inhibitors for Lung #Cancer.
Anaplastic Lymphoma Kinase (ALK) fusion/rearrangement is the second most common driver gene mutation, occurring in approximately 3%-7% of cases....
#lungcancer #oncology #CancerResearch #Cancers #cancersurvivor
2
94
Kate retweeted
2 Sep 2023
BL-B01D1 elicited antitumor activity w/ a tolerable safety profile in locally advanced or metastatic solid tumors, including NSCLC, regardless of EGFR mutation status. #lcsm #oncology ow.ly/Wh8P50PFsAL
4
6
1,293
Kate retweeted
Congratulations to our ovarian cancer expert Dr Intidhar Labidi-Galy @UNIGEnews @Hopitaux_unige and colleagues for her work identifying mechanisms of efficacy of PARP inhibitors in ovarian cancer depending on the precise location of the mutation on the BRCA gene. @Annals_Oncology
An international team led by @unige_en, @Hopitaux_unige, @CLCCLeonBerard, @institut_curie, @ArcagyGineco and the ENGOT consortium reveals the importance of localizing #BRCA #gene mutations in #ovarian #cancer treatment.
ow.ly/lBlq50LKU2P
1
6
8
Targeted treatment is the way!
6 Jul 2023
Molecular analysis revealed potential treatment options for 69.3% of patients. Identifying TP53 E285K mutation prevalence and features associated with treatment benefit could pave the way for targeted therapies. #CancerTreatment ow.ly/mqP750P2Vsj
1
33
Kate retweeted
16 Jun 2023
New research: Colorectal cancer in patients of advanced age is associated with increased incidence of BRAF p.V600E mutation and mismatch repair deficiency: Introduction
The highest incidence of colorectal cancer (CRC) is in patients diagnosed… #oncology frontiersin.org/articles/10.…
2
246
Kate retweeted
21 Jun 2023
Gotta catch them all (every mutation of clinical significance) #TumorBoardTuesday
2
6
149
And yet, hospital admins STILL just can't figure out why we leave the bedside in droves.
23 Jun 2023
My friend who is an RN just told me that her co-worker didn’t get approved time off for her own wedding. Wtf are we doing to our own over here in healthcare.
28
Kate retweeted
1 Jun 2023
NEW #PaperoftheDay: "Association of mutation and expression of the brother of the regulator of imprinted sites (BORIS) gene with breast cancer progression" doi.org/10.18632/oncotarget.… #cancerresearch #oncology #openaccess #peerreviewed #medEd #OA
1
79
Kate retweeted
16 Apr 2023
A hot topic - #KRAS @AACR #AACR23 #AACR2023
Overcoming resistance to drugs targeting KRASG12C mutation @The_InnovationJ @Innov_Medicine
Intrinsic and Acquired Resistance to Drugs Targeting K-RasG12C cell.com/the-innovation/pdf/… #kras #oncology #CancerResearch #cancersurvivor #cancers #InnoMed #MedEd #MedTwitter
1
21
81
57,507
Pretty exciting!
13 Dec 2022
Accelerated approval by @US_FDA for KRAZATI (@Mirati Adagrasib) in locally advanced or metastatic #LungCancer with KRAS G12C mutation.
And then there were two (KRAZATI & LUMAKRAS).
accessdata.fda.gov/scripts/c…
30
Kate retweeted
7 Mar 2023
A new library documenting mutations can help explain why some #cancers don't respond to #immunotherapies. Researchers from @sangerinstitute used #CRISPR gene editing technology and mini tumors to understand the role of mutations in #bowelcancer cell lines: ow.ly/4IOe50Nb0iS
1
1
466